Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
35801
35802
35803
35804
35805
35806
35807
35808
35809
35810
35811
35812
35813
35814
35815
35816
35817
35818
35819
35820
35821
35822
35823
35824
35825
35826
35827
35828
35829
35830
35831
35832
35833
35834
35835
35836
35837
35838
35839
35840
35841
35842
35843
| UnnamedSample_HQ_transcript/15698|m.5614 | UnnamedSample_HQ_transcript/15698 | Coverage 0.974 too low. | 5d9300fb1f3faaa40e2f07b4bc510f82 | 288 | Pfam | PF00628 | PHD-finger | 237 | 283 | 3.6E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/1272|m.752 | UnnamedSample_HQ_transcript/1272 | Unmapped. | babb55b103af4e19f79f4063e5a87b83 | 1195 | Pfam | PF08762 | CRPV capsid protein like | 215 | 425 | 5.7E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/1272|m.752 | UnnamedSample_HQ_transcript/1272 | Unmapped. | babb55b103af4e19f79f4063e5a87b83 | 1195 | Pfam | PF00910 | RNA helicase | 839 | 947 | 4.0E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/67254|m.17452 | UnnamedSample_HQ_transcript/67254 | Coverage 0.447 too low. | b87d92265d210a32985b08bcd6083a94 | 518 | Pfam | PF07701 | Heme NO binding associated | 189 | 293 | 9.7E-29 | T | 22-09-2020 | IPR011645 | Haem NO binding associated |
| UnnamedSample_HQ_transcript/67254|m.17452 | UnnamedSample_HQ_transcript/67254 | Coverage 0.447 too low. | b87d92265d210a32985b08bcd6083a94 | 518 | Pfam | PF07701 | Heme NO binding associated | 103 | 182 | 3.0E-13 | T | 22-09-2020 | IPR011645 | Haem NO binding associated |
| UnnamedSample_HQ_transcript/67254|m.17452 | UnnamedSample_HQ_transcript/67254 | Coverage 0.447 too low. | b87d92265d210a32985b08bcd6083a94 | 518 | Pfam | PF00211 | Adenylate and Guanylate cyclase catalytic domain | 300 | 470 | 6.7E-62 | T | 22-09-2020 | IPR001054 | Adenylyl cyclase class-3/4/guanylyl cyclase |
| UnnamedSample_HQ_transcript/108619|m.23662 | UnnamedSample_HQ_transcript/108619 | Coverage 0.888 too low. | fed66afeb73a06335fbdb63a4df6afdf | 249 | Pfam | PF14580 | Leucine-rich repeat | 19 | 147 | 5.8E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/112423|m.24128 | UnnamedSample_HQ_transcript/112423 | Coverage 0.880 too low. | fed66afeb73a06335fbdb63a4df6afdf | 249 | Pfam | PF14580 | Leucine-rich repeat | 19 | 147 | 5.8E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12353|m.4607 | UnnamedSample_HQ_transcript/12353 | Identity 0.841 too low. | 6899ca8f2e488a30d7f1a9a4e82e1238 | 219 | Pfam | PF00581 | Rhodanese-like domain | 112 | 183 | 2.8E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/105710|m.23308 | UnnamedSample_HQ_transcript/105710 | Coverage 0.985 too low. | 77c9237b5b788eff02b36e0646154829 | 210 | Pfam | PF01269 | Fibrillarin | 2 | 204 | 1.0E-100 | T | 22-09-2020 | IPR000692 | Fibrillarin |
| UnnamedSample_HQ_transcript/7447|m.3004 | UnnamedSample_HQ_transcript/7447 | Coverage 0.604 too low. | 6266443d8ab53ccc0847b5bbcb1991e8 | 1043 | Pfam | PF12738 | twin BRCT domain | 210 | 250 | 1.1E-4 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/7447|m.3004 | UnnamedSample_HQ_transcript/7447 | Coverage 0.604 too low. | 6266443d8ab53ccc0847b5bbcb1991e8 | 1043 | Pfam | PF12738 | twin BRCT domain | 115 | 177 | 5.7E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/7447|m.3004 | UnnamedSample_HQ_transcript/7447 | Coverage 0.604 too low. | 6266443d8ab53ccc0847b5bbcb1991e8 | 1043 | Pfam | PF00621 | RhoGEF domain | 599 | 780 | 7.6E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/28188|m.9013 | UnnamedSample_HQ_transcript/28188 | Coverage 0.882 too low. | 7d756fe743a097c3c53e60cb8ff0bca4 | 536 | Pfam | PF01846 | FF domain | 104 | 153 | 1.8E-11 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/28188|m.9013 | UnnamedSample_HQ_transcript/28188 | Coverage 0.882 too low. | 7d756fe743a097c3c53e60cb8ff0bca4 | 536 | Pfam | PF01846 | FF domain | 463 | 504 | 2.0E-5 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/28188|m.9013 | UnnamedSample_HQ_transcript/28188 | Coverage 0.882 too low. | 7d756fe743a097c3c53e60cb8ff0bca4 | 536 | Pfam | PF01846 | FF domain | 319 | 374 | 3.7E-10 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/28188|m.9013 | UnnamedSample_HQ_transcript/28188 | Coverage 0.882 too low. | 7d756fe743a097c3c53e60cb8ff0bca4 | 536 | Pfam | PF01846 | FF domain | 241 | 294 | 2.0E-4 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/50328|m.14091 | UnnamedSample_HQ_transcript/50328 | Coverage 0.751 too low. | ba849480c9b768863f8fc083582df6d1 | 470 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 399 | 456 | 1.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/50328|m.14091 | UnnamedSample_HQ_transcript/50328 | Coverage 0.751 too low. | ba849480c9b768863f8fc083582df6d1 | 470 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 305 | 363 | 4.3E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/50328|m.14091 | UnnamedSample_HQ_transcript/50328 | Coverage 0.751 too low. | ba849480c9b768863f8fc083582df6d1 | 470 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 94 | 150 | 6.4E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/50328|m.14091 | UnnamedSample_HQ_transcript/50328 | Coverage 0.751 too low. | ba849480c9b768863f8fc083582df6d1 | 470 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 197 | 252 | 2.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/50328|m.14091 | UnnamedSample_HQ_transcript/50328 | Coverage 0.751 too low. | ba849480c9b768863f8fc083582df6d1 | 470 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 123 | 171 | 1.9E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/49081|m.13823 | UnnamedSample_HQ_transcript/49081 | Coverage 0.635 too low. | b036d0d4c72f1431d76113c8795bdc3d | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/49081|m.13823 | UnnamedSample_HQ_transcript/49081 | Coverage 0.635 too low. | b036d0d4c72f1431d76113c8795bdc3d | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 1.3E-44 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/32557|m.10096 | UnnamedSample_HQ_transcript/32557 | Coverage 0.844 too low. | 2f315e68d3cee5c4465614f91750c45e | 477 | Pfam | PF07690 | Major Facilitator Superfamily | 2 | 342 | 8.5E-29 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/100067|m.22651 | UnnamedSample_HQ_transcript/100067 | Coverage 0.935 too low. | 046c2f4c8a1f18d5b23755818ea8755d | 117 | Pfam | PF13417 | Glutathione S-transferase, N-terminal domain | 5 | 80 | 3.2E-16 | T | 22-09-2020 | IPR004045 | Glutathione S-transferase, N-terminal |
| UnnamedSample_HQ_transcript/52352|m.14518 | UnnamedSample_HQ_transcript/52352 | Coverage 0.884 too low. | a2b71e5ccf534d91fcee801eb56c9316 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 35 | 355 | 8.4E-18 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/56455|m.15329 | UnnamedSample_HQ_transcript/56455 | Coverage 0.932 too low. | a2b71e5ccf534d91fcee801eb56c9316 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 35 | 355 | 8.4E-18 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/66773|m.17361 | UnnamedSample_HQ_transcript/66773 | Coverage 0.920 too low. | a2b71e5ccf534d91fcee801eb56c9316 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 35 | 355 | 8.4E-18 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/45660|m.13068 | UnnamedSample_HQ_transcript/45660 | Identity 0.912 too low. | ab2ef823a400a2bf0d37ba5006854701 | 466 | Pfam | PF00069 | Protein kinase domain | 154 | 378 | 7.7E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/13554|m.4965 | UnnamedSample_HQ_transcript/13554 | Coverage 0.405 too low. | d5705ce00f60635154d4c14497680eed | 878 | Pfam | PF04564 | U-box domain | 801 | 872 | 3.5E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/13554|m.4965 | UnnamedSample_HQ_transcript/13554 | Coverage 0.405 too low. | d5705ce00f60635154d4c14497680eed | 878 | Pfam | PF10408 | Ubiquitin elongating factor core | 127 | 784 | 1.6E-167 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00102 | Protein-tyrosine phosphatase | 1274 | 1503 | 3.5E-77 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 192 | 273 | 1.5E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 563 | 636 | 2.0E-12 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 101 | 175 | 1.5E-8 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 299 | 368 | 3.1E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 384 | 462 | 2.5E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 851 | 918 | 2.8E-8 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF00041 | Fibronectin type III domain | 942 | 1024 | 1.1E-8 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/1199|m.720 | UnnamedSample_HQ_transcript/1199 | Coverage 0.563 too low. | 8892e6430a461f0df7c0ffa513d9265c | 1535 | Pfam | PF18861 | Transmembrane domain of protein tyrosine phosphatase, receptor type J | 1060 | 1200 | 2.3E-18 | T | 22-09-2020 | IPR041201 | PTPRJ, transmembrane domain |
| UnnamedSample_HQ_transcript/101695|m.22834 | UnnamedSample_HQ_transcript/101695 | Coverage 0.889 too low. | c4a5c60dea7053d2d63eea90dba85639 | 270 | Pfam | PF00651 | BTB/POZ domain | 66 | 166 | 3.5E-6 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/65805|m.17167 | UnnamedSample_HQ_transcript/65805 | Coverage 0.893 too low. | 6cb472aa26e5eede7827373b0308dfa6 | 470 | Pfam | PF07690 | Major Facilitator Superfamily | 216 | 400 | 7.9E-31 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
